State Of Alaska, Department Of Revenue Vanda Pharmaceuticals Inc. Transaction History

State Of Alaska, Department Of Revenue

$9.42 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 24, 2023	SELL	$5.9 - $6.95 $6,419 - $7,561	-1,088 Reduced 2.8%	37,797 $249,000
Q1 2023 Apr 17, 2023	SELL	$6.18 - $7.99 $3,213 - $4,154	-520 Reduced 1.32%	38,885 $264,000
Q4 2022 Jan 11, 2023	BUY	$6.87 - $10.96 $1,690 - $2,696	246 Added 0.63%	39,405 $291,000
Q3 2022 Oct 20, 2022	SELL	$9.44 - $11.76 $33,691 - $41,971	-3,569 Reduced 8.35%	39,159 $386,000
Q2 2022 Jul 08, 2022	BUY	$9.31 - $11.84 $36,960 - $47,004	3,970 Added 10.24%	42,728 $465,000
Q1 2022 Apr 14, 2022	SELL	$10.84 - $16.55 $7,479 - $11,419	-690 Reduced 1.75%	38,758 $438,000
Q4 2021 Jan 12, 2022	SELL	$15.69 - $21.14 $17,886 - $24,099	-1,140 Reduced 2.81%	39,448 $618,000
Q3 2021 Oct 07, 2021	BUY	$15.35 - $21.27 $32,925 - $45,624	2,145 Added 5.58%	40,588 $695,000
Q2 2021 Jul 12, 2021	BUY	$15.71 - $21.51 $20,218 - $27,683	1,287 Added 3.46%	38,443 $826,000
Q1 2021 Apr 09, 2021	SELL	$13.42 - $20.28 $72,602 - $109,714	-5,410 Reduced 12.71%	37,156 $558,000
Q4 2020 Jan 08, 2021	SELL	$9.77 - $13.81 $83,728 - $118,351	-8,570 Reduced 16.76%	42,566 $559,000
Q3 2020 Oct 05, 2020	SELL	$9.32 - $12.02 $279 - $360	-30 Reduced 0.06%	51,136 $493,000
Q2 2020 Jul 06, 2020	BUY	$9.66 - $12.02 $16,325 - $20,313	1,690 Added 3.42%	51,166 $585,000
Q1 2020 Apr 06, 2020	BUY	$7.5 - $16.8 $69,000 - $154,560	9,200 Added 22.84%	49,476 $512,000
Q4 2019 Jan 07, 2020	SELL	$12.38 - $17.47 $7,304 - $10,307	-590 Reduced 1.44%	40,276 $660,000
Q3 2019 Oct 02, 2019	BUY	$12.27 - $15.79 $280,197 - $360,580	22,836 Added 126.66%	40,866 $542,000
Q2 2019 Jul 23, 2019	BUY	$13.37 - $18.85 $3,850 - $5,428	288 Added 1.62%	18,030 $254,000
Q1 2019 Apr 09, 2019	BUY	$17.59 - $31.05 $2,902 - $5,123	165 Added 0.94%	17,742 $326,000
Q4 2018 Jan 10, 2019	BUY	$18.97 - $31.47 $2,845 - $4,720	150 Added 0.86%	17,577 $459,000
Q3 2018 Oct 09, 2018	BUY	$18.25 - $23.0 $318,042 - $400,821	17,427 New	17,427 $399,000

Others Institutions Holding VNDA

# of Institutions

161

Shares Held

45.2M

Call Options Held

165K

Put Options Held

33.6K

Black Rock Inc. New York, NY

8.14M
Shares

$39.5 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

4.01M
Shares

$19.5 Million
0.03% of portfolio
Vanguard Group Inc Valley Forge, PA

3.63M
Shares

$17.6 Million
0.0% of portfolio
Tang Capital Management LLC San Diego, CA

2.35M
Shares

$11.4 Million
0.94% of portfolio
Dimensional Fund Advisors LP Austin, TX

2.26M
Shares

$11 Million
0.0% of portfolio

View Full List

About Vanda Pharmaceuticals Inc.

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $274M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

More about VNDA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Alaska, Department Of Revenue, based on Form 13F filings with the SEC.

News

Stay updated on State Of Alaska, Department Of Revenue with notifications on news.

Account